In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Adma Biologics Inc (NASDAQ: ADMA) closed the day trading at $15.78 down -2.11% from the previous closing price of $16.12. In other words, the price has decreased by -$2.11 from its previous closing price. On the day, 4.15 million shares were traded. ADMA stock price reached its highest trading level at $16.18 during the session, while it also had its lowest trading level at $15.75.
Ratios:
For a better understanding of ADMA, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 41.68 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 55.19. For the most recent quarter (mrq), Quick Ratio is recorded 2.80 and its Current Ratio is at 6.87. In the meantime, Its Debt-to-Equity ratio is 0.75 whereas as Long-Term Debt/Eq ratio is at 0.74.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 09 ’24 when Guiheen Lawrence P. sold 9,000 shares for $18.47 per share. The transaction valued at 166,189 led to the insider holds 153,941 shares of the business.
Guiheen Lawrence P. bought 9,000 shares of ADMA for $146,340 on Sep 09 ’24. On Aug 30 ’24, another insider, Kestenberg-Messina Kaitlin M., who serves as the COO and SVP, Compliance of the company, sold 24,150 shares for $16.90 each. As a result, the insider received 408,050 and left with 449,088 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADMA now has a Market Capitalization of 3678049792 and an Enterprise Value of 3731201024. As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 112.23, and their Forward P/E ratio for the next fiscal year is 24.09. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.14 while its Price-to-Book (P/B) ratio in mrq is 19.53. Its current Enterprise Value per Revenue stands at 11.298 whereas that against EBITDA is 39.237.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $21.13, while it has fallen to a 52-week low of $3.06. The 50-Day Moving Average of the stock is -12.62%, while the 200-Day Moving Average is calculated to be 50.00%.
Shares Statistics:
Over the past 3-months, ADMA traded about 5.24M shares per day on average, while over the past 10 days, ADMA traded about 6264600 shares per day. A total of 226.06M shares are outstanding, with a floating share count of 225.20M. Insiders hold about 3.38% of the company’s shares, while institutions hold 80.02% stake in the company. Shares short for ADMA as of 1727654400 were 17079555 with a Short Ratio of 3.26, compared to 1724976000 on 9499242. Therefore, it implies a Short% of Shares Outstanding of 17079555 and a Short% of Float of 7.550000399999999.
